ArticleDisease markers2022

lncRNA CDKN2B-AS1 Could Be an Indicator to Identify Prognosis and Status of Immune Microenvironment in Thyroid Cancer.

Cheng Xue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.